Pharmaceuticals - World Trademark Review

Pharmaceuticals

Board of Appeal rebuked by General Court for ruling of its own motion on earlier mark's genuine use

In invalidity proceedings between Glaxo Group and Celon Pharma, the EU General Court has held that the Board of Appeal of the EUIPO did not have the competence to rule of its own motion on the earlier mark's genuine use.

Read more

“We try to take smart risks”: Sandoz International’s business-focused reproach to rights management

How Sandoz International, this year’s WTR Industry Awards Healthcare and Life Sciences Team of the Year, adapts its enforcement strategies to keep one step ahead of infringers.

Read more

Vilnius District Court: no likelihood of confusion between SATI-formative marks

A Lithuanian court has dismissed an action for the invalidation of the mark SATIMED for goods and services in Classes 3, 5 and 42, and the mark SATIVERA for goods in Class 3, based on the earlier marks SATIVEX.

Read more

Know your audience: the importance of the relevant public when determining distinctiveness

The EU General Court has considered whether the mark VSL#3 in Class 5 had become the common name in the trade for the products at issue, and whether the mark misled the public because of its use.

Read more

Novichok trademark flurry, gift shop seeks IT'S COMING HOME mark and IHOb is no more: news round-up

In our latest round-up, we look at the UK gift shop seeking registered trademark protection for "It's coming home", the new Cornish pasties authentication scheme, Kenya stepping up its anti-counterfeit efforts, and much...

Read more

Bayer retires Monsanto brand, cocky trademark struck down and Nigeria kit attracts counterfeiters: news round-up

In our latest round-up, we look at Bayer deciding to retire the century-old Monsanto brand name, Kenzo prevailing in a trademark suit, Kenya Revenue authority destroying millions worth of fake alcohol, and much...

Read more

The world’s leading corporate trademark professionals revealed

Released today, Apple, Mars and Procter & Gamble head up the 2018 edition of the WTR 300: The World’s Leading Corporate Trademark Professionals. Now in its second edition, this community-led research project identifies the leading lights of the corporate...

Read more

WTR Industry Awards 2018: the shortlist revealed

The WTR Industry Awards 2018 honour leading trademark teams and individuals across a range of sectors. We reveal the shortlist.

Read more

Procedures and strategies for pharmaceutical brands: Chile

Two frameworks are applicable to pharmaceutical marks in Chile. The Industrial Property Law and its regulation set out the rules for the registration and use of trademarks; the Sanitary Code and Decree 3/2010 regulate the pharmaceutical product marketing authorisation...

Read more

Procedures and strategies for pharmaceutical brands: Canada

Sweeping amendments to the Trademarks Act are expected to be implemented in 2019. The amendments will fundamentally affect the way in which all trademark owners will need to approach their selection, clearance and registration strategies, and the pharmaceutical...

Read more

Procedures and strategies for pharmaceutical brands: Brazil

Brazil is a first-to-file jurisdiction, and therefore IP rights are acquired only when an application is filed and registered with the Brazilian Patent and Trademark Office. However, pharmaceutical trademarks fall under two separate and independent statutory regimes...

Read more

Procedures and strategies for pharmaceutical brands: France

In order for a pharmaceutical trademark to be registered, no prior authorisation is needed per se. Unlike in other countries, in France the trademark owner is independent from the party exploiting the trademark and need not possess a particular quality.

Read more

Healthcare market robust – brands prosper while Chinese filings dominate: exclusive data analysis

In our latest industry data report, we explore the thriving and evolving healthcare industry. Our in-depth analysis reveals the trends driving this evolution, while also analysing key trademark filing statistics in this space...

Read more

Big changes in the pharmaceutical sector as leading brands flourish

A deep dive into key data about the pharmaceuticals sector suggests that over-regulation and availability of skills and technology remain key challenges; while the leading brands continue to rise in value, most are still filing in single classes only.

Read more

Big changes in the pharmaceutical sector as leading brands flourish: exclusive data analysis

In this week’s data report, we turn the spotlight on the sprawling pharmaceutical sector. We look at how the sector is being affected by political pressures, and identify the developments that are driving change.

Read more
Close

Register for more free content

  • Read more World Trademark Review blogs and articles
  • Receive the editor's weekly review by email
Register now  
Issue 74
;